Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-month oral oxycodone after total knee arthroplasty
IRCT20220413054520N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in postoperative pain and knee osteoarthritis (OA) comparing Oxycodone group with Placebo group (2 arms). Primary endpoints: knee pain, knee function and 3 more. Started Jul 2023; status: completed.
02
Drugs
oxycodone
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20220413054520N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220413054520N1.